Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

Abstract Background Newer oral antidiabetic drug classes are expanding treatment options for type 2 diabetes mellitus (T2DM); however, concerns remain. The objective was to assess relative risk of heart failure hospitalization of sodium–glucose co-transporter-2 (SGLT2) and dipeptidyl peptidase-4 (DP...

Full description

Bibliographic Details
Main Authors: Santosh Gautam, Abiy Agiro, John Barron, Thomas Power, Harry Weisman, Jeff White
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Cardiovascular Diabetology
Subjects:
SGLT2
DPP4
Type 2 diabetes
OAD
Heart failure
Claims analysis
Online Access:http://link.springer.com/article/10.1186/s12933-017-0575-x

Internet

http://link.springer.com/article/10.1186/s12933-017-0575-x

Similar Items